Study Stopped
The study was not developed due to the cessation of IONSYS marketing
Association Between Patients' Perceptions of Success in Post-op Pain Management and Overall Experience With Care
Assessing the Association Between Patients' Perceptions of Success With Post-Operative Pain Management and Overall Experience With Care
1 other identifier
observational
N/A
1 country
9
Brief Summary
Assessing the association between patients' perceptions of success with post-operative pain management and overall experience with care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2015
Shorter than P25 for all trials
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 2, 2015
CompletedFirst Posted
Study publicly available on registry
March 17, 2015
CompletedStudy Start
First participant enrolled
June 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2015
CompletedApril 26, 2018
April 1, 2018
2 months
March 2, 2015
April 24, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Patient Global Assessment (PGA) and Hospital Consumer Assessment of Healthcare providers and Systems (HCAHPS)
Assess the association between patients' perceptions of success with opioid post-operative pain management following total hip replacement or hysterectomy surgery as measured by a patient global assessment (PGA) at 24 hours post-op and at 48 hours post-op, and their perception of pain management while in the hospital and the hospital overall, as measured by the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) instrument two-weeks (14 days) post-discharge
24 hours - 14 days post discharge
Secondary Outcomes (1)
Post-Operative Pain Management Modality
14 days post discharge
Other Outcomes (1)
Composite outcome measures consisting of multiple measures
48 Hours Post Op
Study Arms (2)
Total Hip Replacement Group
Adults who have undergone a total hip replacement
Hysterectomy Group
Adults who have undergone a hysterectomy
Eligibility Criteria
Study population will include adults 18 years of age or older who have undergone either a total hip replacement or hysterectomy.
You may qualify if:
- Subject must be 18 years of age or older
- Subject (or their legally acceptable representative) must have signed an informed consent form (ICF) indicating that they understand the purpose of and procedures required for the study and are willing to participate in the study
- Subject is receiving a unilateral total hip replacement or a hysterectomy (total abdominal hysterectomy, total abdominal hysterectomy/bilateral salpingo-oophorectomy, total vaginal hysterectomy, or total vaginal hysterectomy/salpingo-oophorectomy)
- Subject is expected to remain hospitalized for at least 24 hours post-operatively
- Subject is expected to experience pain requiring IV PCA or non-PCA (non-patient controlled opioids via IV, IM, SC, or PO routes of administration) opioids for at least 24 hours after surgery
- Subject is classified as American Society of Anesthesiology (ASA) category I, II, or III
- Subject is willing to complete the required post-operative survey measures to be completed in the hospital
- Subject is willing to complete a post-discharge survey (including HCAHPS survey instrument) via telephone approximately two-weeks (14 days) post-discharge
You may not qualify if:
- Subject cannot read, write, and communicate in English
- Subject has a history of tolerance to opioids including those prescribed opioids in the 3 month period leading up to the perioperative period (i.e., a subject is considered to have a potential tolerance to opioids if for 4 consecutive days prior to surgery they have been taking a short acting/short acting combination opioid analgesic greater than 120 mg codein daily, 40 mg hydrocodone daily, 200 mg tramadol daily, or 40 mg oxycodone daily or if they were on any dose of strong opioid analgesic such as morphine, hydromorphone, or fentanyl)
- Subject has a history of allergy to opioids reported pre-operatively or documented in medical history
- Subject is scheduled to receive additional surgical procedures beyond those listed within 72 hours of the initial surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (9)
Bridgeport Hospital
Bridgeport, Connecticut, 06610, United States
Jupiter Medical Center
Jupiter, Florida, 33458, United States
Phoenix Clinical Research LLC
Tamarac, Florida, 33321, United States
Henry Ford Health System
Detroit, Michigan, 48202, United States
Orthopaedic Associates of Michigan
Grand Rapids, Michigan, 49525, United States
Drexel University
Philadelphia, Pennsylvania, 19104, United States
Magee-Women's Hospital (UPMC)
Pittsburgh, Pennsylvania, 15213, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15232, United States
Baylor Health Research Institute
Fort Worth, Texas, 76104, United States
Related Publications (2)
Cohen J. A power primer. Psychol Bull. 1992 Jul;112(1):155-9. doi: 10.1037//0033-2909.112.1.155.
PMID: 19565683RESULTCohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Earlbaum Associates.
RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jeffrey Abraham, MSPT, MBA
The Medicines Company
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 14 Days
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 2, 2015
First Posted
March 17, 2015
Study Start
June 1, 2015
Primary Completion
August 1, 2015
Study Completion
August 1, 2015
Last Updated
April 26, 2018
Record last verified: 2018-04